NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aerin Medical

Aerin Medical

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://aerinmedical.com/

Last Round

Debt

Jan 13, 2025

Total Funding Raised

$103.7M

Company Overview

Aerin Medical is a medical device company that develops non-invasive therapeutic devices designed to enhance nasal breathing and address chronic nasal airway conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

minimally invasive surgeryENT medical devicesoffice-based proceduresnasal airway obstructionchronic rhinitisradiofrequency ablationotolaryngologyin-office ENTnasal surgery alternativesmedical device disposablesrhinoplasty alternativesnasal valve repairENT tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aerin Medical Comps

Public and private peers based on sector, stage, and business model.

Aerin Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aerin Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJan 13, 2025
Series GJan 13, 2025
VC RoundJun 16, 2022
VC RoundAug 17, 2020
DebtMay 21, 2019
Series C
Mar 22, 2016

Key People

Founding team and executive leadership

John Chang

Founder And Chief Technical Officer

Founding Team

Andre Cheng

Chief Financial Officer & Chief Strategy Officer

Executive Team

Derrick Sung

Chief Financial Officer

Executive Team

Aerin Medical Investors

Notable investors and investment history

Aerin Medical investors
InvestorRounds
KCK MedTechVC Round, Series G
KCK Global LimitedVC Round, Series C
Ally Bridge GroupSeries G, VC Round
Questa CapitalVC Round, Series G
OrbiMedVC Round, Series G
Ares Management CorporationSeries G, Debt
KCK FZESeries C, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 24, 2025

    Launched next-generation RhinAer for chronic rhinitis treatment.

  • Jan 13, 2025

    Completed a debt financing round.

Aerin Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aerin Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aerin Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMountain View, California
Employee Range156
Year Founded2011
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.